SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

60 Degrees Pharmaceuticals Reports Clinical Improvement in Completed Babesiosis Study Patients

The company said all five completed expanded-access study patients reported much or very much improved clinical outcomes and tested negative by PCR.

SXTPSXTPW

Related stories